Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM) -- Ignore unavailable to you. Want to Upgrade?

To: mike n. who wrote (520)	10/13/2004 12:29:31 AM
From: Dick Martin	Read Replies (1) \| Respond to of 655

QTL Biosystems seems to have a good test platform although it is evident that this is still very much a developement stage, whereas Ramp is in use and approved by FDA and tested independently by several labs. A few years down the road they may be competition but look how long it has taken RBM to make commercial sales. In the long term we are going to have competition and probably from yet unknown technology although if RBM can grab market share right now there will be revenue to continue research or acquire new tests.Our shares are up good in the last little while and the time is ripe for an annoucement so we really got to hear something soon. Holding On Dick